Exclusive: Former Merck scientists raise $85M to map and drug protein interactions in cancer and autoimmune disease

Ryan Cross

Senior Science Correspondent

The surfaces of cells are studded with proteins used to communicate with neighbors and visitors. A new method for mapping them and their interactions is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Exclusive: Former Merck scientists raise $85M to map and drug protein interactions in cancer and autoimmune disease

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Trump blog: Judge extends nationwide block on NIH payment cuts

RFK Jr. readies review of childhood vaccine schedule after pledging not to

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Ex­clu­sive: For­mer Mer­ck sci­en­tists raise $85M to map and drug pro­tein in­ter­ac­tions in can­cer and au­toim­mune dis­ease

Senior Science Correspondent

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Exclusive: Former Merck scientists raise $85M to map and drug protein interactions in cancer and autoimmune disease